Clinical benefits and controversies of jejunostomy feeding in patients undergoing gastrectomy for gastric cancer  

作　　者：Martino Munini Margot Fodor Alessio Corradi Antonio Frena 

机构地区：[1]Department of General and Pediatric Surgery,Bolzano Central Hospital,Bolzano 39100,Trentino-Alto Adige,Italy

出　　处：《World Journal of Gastrointestinal Surgery》2025年第3期422-426,共5页世界胃肠外科杂志(英文)

摘　　要：Globally,gastric cancer ranks as the fifth most common malignancy and the third leading cause of cancer-related mortality.Gastrectomy combined with periop-erative chemotherapy is currently the standard of care in locally advanced stages,but the completion rate of multimodal approach is influenced also by patient related factors.Malnutrition is a well-known risk factor associated with poor oncological outcomes.Its perioperative supplementation could lead to an im-provement of the nutritional status.This article reviews and comments the retro-spective study conducted by Jaquet et al,which evaluates the impact of enteral nutrition by jejunostomy feeding in patients undergoing gastrectomy for cancer.The authors included 172 patients,35%of whom received jejunostomy.Patients with optimized biological nutritional parameters(body mass index,albumin,prealbumin)showed reduced major complications(>III),according to the Dindo-Clavien classification,0(0%)vs 8(4.7%)(P=0.05).In the era of multimodal treatment,optimization of nutritional and performance status is integral part of the therapeutic strategy.

关 键 词：Gastric cancer Feeding jejunostomy MALNUTRITION 

分 类 号：R73[医药卫生—肿瘤]